Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
2.640
+0.080 (3.13%)
At close: Feb 6, 2026, 4:00 PM EST
2.680
+0.040 (1.52%)
After-hours: Feb 6, 2026, 7:43 PM EST
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $29.53 million as of February 6, 2026. Its market cap has decreased by -34.34% in one year.
Market Cap
29.53M
Enterprise Value
17.26M
1-Year Change
-34.34%
Ranking
Category
Stock Price
$2.64
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has decreased from $30.33M to $29.53M, a decrease of -2.65%. That is a compound annual growth rate of -0.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 29.53M | -12.87% |
| Dec 31, 2025 | 33.89M | -1.50% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dyadic International | 30.17M |
| TuHURA Biosciences | 30.00M |
| Passage Bio | 29.91M |
| Rein Therapeutics | 29.88M |
| Werewolf Therapeutics | 29.69M |
| AN2 Therapeutics | 29.05M |
| NeuroSense Therapeutics | 28.94M |
| Marker Therapeutics | 28.71M |